1Choudhry S, Bagga A, Hari P, et al. Efficacy and safety o f tacrolimus versus cyclosporine in children with steroid- resistant nephrotic syndrome: a randomized controlled trial [J]. Am J Kidney Dis, 2009, 53( 5): 760- 769.
2Butan ! L, Rainsamo J R. Experience with tacrolimus in children with steroid- resistant nephrotic syndrome [J]. Pediatr Nephrol, 2009, 4( 8): 1517- 1523.
3Westhoff TH,van der Giet M. Tacrolimus in the treatment of idiopathic nephrotic syndrome[J]. Expert Opin Investig Drugs,2007, 16:1099 -1110.
4Loeffler K,Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotie syndrome[ J ]. Pediatr Nephrol,2004 ,19 :281 - 287.
5Sinha MD, Macteod R, Rigby E ,et al. Treatment of severe steroid-dependent nephrotic syndrome(SDNS) in children with tacrolimus [ J]. Nephrol Dial Transplant,2006,21 : 1848 - 1854.
6Segarra A, Vila J, Pou L, et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis : a preliminary uncontrolled study with prospective follow-up [ J ]. Nephrol Dial Transplant, 2002,17 : 655 - 662.
7Miao L,Sun J, Yuan H, et al. Combined therapy of low-dose taerolimus and prednisone in nephrotie syndrome with slight mesangial proliferation [ J ]. Nephrology ,2006,11:449 - 454.
8Li X, Li H,Chen J,et al. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome [J]. Nephrol Dial Transplant, 2007 Oct 1, [ Epub ahead of print ].
9Praga M, Barrio V, Juarez GF, et al. Taerolimus monotherapy in membranous nephropathy: a randomized controlled trial [ J ]. Kidney Int ,2007,71:924 - 30.
10Duncan N, Dhaygudea A, Owen J, et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy [J]. Nephrol Dial Transplant ,2004,19:3062 - 3067.
6Gloor J, Stegall M D. Sensitized renal transplant recipi- ents : current protocols and future directions [ J ]. Nat Rev Nephrol, 2010,6 ( 5 ) :297-306.
7Thompson J S, Thacker L R, Krishnan G. Human leuko- cyte antigens DR and AB and kidney retransplantation [ J ]. Transplantation, 2003,75 ( 5 ) :718-723.
9Bellingham J M, Santhanakrishnan C, Neidlinger N, et al. Donation after cardiac death: a 29-year experience[J].Surgery, 2011,150(4) :692-702.
10Saidi R F, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and dona- tion after cardiac death kidneys: realities and costs[ J]. Am J Transplant, 2007,7(12) :2769-2774.
